 | Up a level |
de Stefano, Nicola; Barkhof, Frederik; Montalban, Xavier; Achiron, Anat; Derfuss, Tobias; Chan, Andrew; Hodgkinson, Suzanne; Prat, Alexandre; Leocani, Letizia; Schmierer, Klaus; Sellebjerg, Finn; Vermersch, Patrick; Wiendl, Heinz; Keller, Birgit; Roy, Sanjeev (2022). Early Reduction of MRI Activity During 6 Months of Treatment With Cladribine Tablets for Highly Active Relapsing Multiple Sclerosis: MAGNIFY-MS. Neurology: neuroimmunology & neuroinflammation, 9(4), e1187. Wolters Kluwer Health 10.1212/NXI.0000000000001187
